Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson’s disease ; volume:15 ; number:1 ; day:11 ; month:9 ; year:2024 ; pages:1-14 ; date:12.2024
Stem cell research & therapy ; 15, Heft 1 (11.9.2024), 1-14, 12.2024
- Creator
-
Wang, Xueyao
Han, Deqiang
Zheng, Tianqi
Ma, Jinghong
Chen, Zhiguo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-024-03921-y
- URN
-
urn:nbn:de:101:1-2411252100263.604894646574
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Xueyao
- Han, Deqiang
- Zheng, Tianqi
- Ma, Jinghong
- Chen, Zhiguo
- SpringerLink (Online service)
Other Objects (12)
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
DDAH-1 maintains endoplasmic reticulum-mitochondria contacts and protects dopaminergic neurons in Parkinson’s disease
Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model
Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
DDAH-1 maintains endoplasmic reticulum-mitochondria contacts and protects dopaminergic neurons in Parkinson’s disease
Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model
Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
DDAH-1 maintains endoplasmic reticulum-mitochondria contacts and protects dopaminergic neurons in Parkinson’s disease
Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model